ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $36,261,513 | 17.78% |
| Saturn V Capital Management LP | 636,158 | $8,422,732 | 4.67% |
| MPM BioImpact LLC | 1,745,943 | $23,116,285 | 4.66% |
| Boxer Capital, LLC | 2,154,058 | $28,520 | 1.32% |
| RA Capital Management | 4,417,259 | $58,484,509 | 1.10% |
| Octagon Capital Advisors LP | 596,000 | $7,891,040 | 1.10% |
| BVF INC/IL | 1,810,835 | $23,975,455 | 0.67% |
| 683 Capital Management, LLC | 585,000 | $7,745,400 | 0.56% |
| AlphaCentric Advisors LLC | 63,000 | $834,120 | 0.46% |
| DAFNA Capital Management LLC | 98,560 | $1,304,934 | 0.36% |
| SECTORAL ASSET MANAGEMENT INC | 146,576 | $1,940,666 | 0.32% |
| Artal Group S.A. | 400,000 | $5,296 | 0.16% |
| NinePointTwo Capital LLC | 17,677 | $234 | 0.09% |
| READYSTATE ASSET MANAGEMENT LP | 88,391 | $1,170,297 | 0.09% |
| Worth Venture Partners, LLC | 10,900 | $144,316 | 0.08% |
| Virtus ETF Advisers LLC | 7,773 | $102,915 | 0.06% |
| Candriam S.C.A. | 611,547 | $8,096,882 | 0.06% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 167,804 | $2,221,725 | 0.05% |
| EA Series Trust | 101,304 | $1,341,265 | 0.05% |
| Empowered Funds, LLC | 101,304 | $1,341,265 | 0.05% |
External links
This page lists ITEOS THERAPEUTICS INC's shareholders in Q2 2023. To view ITEOS THERAPEUTICS INC's shareholder history, click here.